ArticleCancers2022

Impact of Progressive Site-Directed Therapy in Oligometastatic Castration-Resistant Prostate Cancer on Subsequent Treatment Response.

Soichiro Yoshida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.